Thrombate III

 Advanced Search
United States
United States | For US Healthcare Professionals Only
Print This Page

Online Resources

Physicians
Anticoagulation Forum. www.acforum.org
ASH: American Society of Hematology. www.hematology.org
ISTH: International Society on Thrombosis and Haemostasis. www.med.unc.edu/isth

Research and Education
ATHN: American Thrombosis and Hemostasis Network. www.athn.net
The Coalition to Prevent Deep-Vein Thrombosis (DVT). www.preventdvt.org
Hemophilia & Thrombosis Research Society. www.htrs.org
NATF: North American Thrombosis Forum. www.natfonline.org
TAP: Thrombophilia Awareness Project. www.fvleiden.org/tap
Vascular Disease Foundation. www.vdf.org

Patients
NATT: The National Alliance for Thrombosis and Thrombophilia. www.nattinfo.org
NHF: National Hemophilia Foundation. www.hemophilia.org

Government
CDC: Centers for Disease Control and Prevention. Blood Disorders: Thrombophilia/Clotting Disorders. www.cdc.gov/ncbddd/hbd/clotting.htm


Important Safety Information
Thrombate III therapy has demonstrated a low occurrence of side effects. In clinical studies with Thrombate III, the most common side effects were dizziness, chest tightness, nausea, and a foul taste in the mouth. As with all plasma-derived therapeutics, the potential to transmit infectious agents, such as viruses, cannot be totally eliminated. Individuals who receive infusions of blood or blood plasma may develop signs and/or symptoms of some viral infections, particularly hepatitis C.

Please see full Prescribing Information for Thrombate III.

Support Your Patients
Efficacy & Safety
Thrombate III Home  |   About Thrombate III  |   About Hereditary AT Deficiency  |   How to Order Thrombate III
Online Resources  |   Prescribing Information  |   Site Map  |   Glossary



 
  Talecris Biotherapeutics   Contact Talecris     General Conditions of Use     Privacy Statement    
 
This site is intended for US healthcare professionals only.
© 2007 Talecris Biotherapeutics, Inc.